| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |